alnylam
The Director of Strategic Pricing & Contracting Analytics leads the development and execution of analytic, financial, and operational capabilities that support pricing and contracting decisions across the organization. This role partners with finance, market access, commercial operations, and advanced analytics to deliver insights, dashboards, and process innovations that improve decision quality and execution.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
13% above the average for this role
Senior Manager, Pricing, Contracting & Revenue Analytics
Bavarian Nordic
Senior Manager, Pricing & Contract Analytics
Sun Pharmaceutical Industries Limited
Senior Director, Market Access Pricing & Contracting
NewAmsterdam Pharma
Director, Strategic Pricing and Contracting
Ipsen
Pricing and Contracting Manager
Cytokinetics
Associate Director, Pricing Strategy & Access Analytics
Amylyx Pharmaceuticals